Exact Sciences Corporation shares rise 1.51% after-hours following AI advancements in healthcare.

Exact Sciences Corporation rose 1.51% in after-hours trading. The company's stock price increase may be attributed to the recent news about the increased usage of AI in healthcare, which is predicted to save lives and money. The World Economic Forum is pushing for the use of AI in healthcare to provide a 'healthier, more equitable world.' Additionally, the publication of new translational research evaluating TGFB2 expression and promoter methylation as potential prognostic markers in pancreatic ductal adenocarcinoma (PDAC) by Oncotelic Therapeutics, Inc. may have contributed to the positive sentiment surrounding the stock.